RVW Wealth’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-271
| Closed | -$2.2K | – | 161 |
|
|
2023
Q1 | $2.2K | Hold |
271
| – | – | ﹤0.01% | 155 |
|
|
2022
Q4 | $3.22K | Buy |
+271
| New | +$3.22K | ﹤0.01% | 150 |
|
|
2022
Q3 | – | Sell |
-271
| Closed | -$10K | – | 134 |
|
|
2022
Q2 | $10K | Hold |
271
| – | – | ﹤0.01% | 126 |
|
|
2022
Q1 | $11K | Hold |
271
| – | – | ﹤0.01% | 136 |
|
|
2021
Q4 | $11K | Hold |
271
| – | – | ﹤0.01% | 136 |
|
|
2021
Q3 | $0 | Hold |
271
| – | – | ﹤0.01% | 124 |
|
|
2021
Q2 | $0 | Hold |
271
| – | – | ﹤0.01% | 110 |
|
|
2021
Q1 | $1M | Hold |
271
| – | – | 0.13% | 103 |
|
|
2020
Q4 | $1M | Hold |
271
| – | – | 0.15% | 95 |
|
|
2020
Q3 | $15K | Hold |
271
| – | – | ﹤0.01% | 96 |
|
|
2020
Q2 | $10K | Hold |
271
| – | – | ﹤0.01% | 93 |
|
|
2020
Q1 | $7K | Buy |
+271
| New | +$7K | ﹤0.01% | 92 |
|